Cancer

InnerMost Launches to Evolve Psychedelic Therapy – Advancing Treatment, Access, and Knowledge in the Field

Uniting FDA-authorized trials, ketamine and Spravato therapy, therapist training, and community education under one roof, InnerMost brings a vital new…

3 months ago

Telomir Pharmaceuticals Announces Telomir-1 Kills Aggressive Human Leukemia Cells

Findings expand Telomir-1's oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and…

3 months ago

Kanazawa University research: Scientists develop a new method to measure cellular energy in real time

KANAZAWA, Japan, Nov. 20, 2025 /PRNewswire/ -- Researchers at the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have developed a…

3 months ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies

VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) ("Onco" or the "Company") is…

3 months ago

MyOme Launches First Integrated Polygenic Risk Score for Prostate Cancer to Advance Early Detection and Personalized Prevention

New whole-genome test uncovers hidden genetic risk beyond traditional screening, empowering earlier and more precise care for millions of men.…

3 months ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

3 months ago

Voio Emerges From Stealth to Build Frontier AI for Healthcare

Voio team’s initial open-source release, Pillar-0, is the world’s most accurate AI model for radiology and builds on the success…

3 months ago

St. Baldrick’s Foundation Awards Nearly $1.2 Million in Grants, Advancing Research and Hope for Kids with Cancer

Los Angeles, California--(Newsfile Corp. - November 20, 2025) - The St. Baldrick's Foundation, the largest charity funder of childhood cancer…

3 months ago

ViVac Appoints Keren Leshem as Chief Executive Officer, Strengthening Leadership to Advance RNA-Lipid Nanoparticle Immunotherapy Platform

JERUSALEM, Nov. 20, 2025 /PRNewswire/ -- ViVac Pharma Ltd., a pioneering synthetic biology company advancing RNA–Lipid Nanoparticle (LNP) immunotherapies, announces the…

3 months ago

Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments

Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat…

3 months ago